Borut Ceh

Deeply characterized samples are already in our inventory. Our collection is meticulously tested for key molecular markers, ensuring that you have access to the most relevant and reliable samples for your studies. 🔬 Our Current Molecular Marker Collection: Thyroid Cancer: Positive for BRAF Colon Cancer: Positive for KRAS Lung Cancer: Positive for ALK Skin Cancer: With BRAF mutation Breast Cancer: Well-characterized samples for HER2, ER, and PR 💡 Why Choose CSD Bio Biobank? Extensive Inventory: Over 50,000 biological samples Ethical Compliance: Adherence to the highest ethical standards and regulatory requirements Trusted Partners: Our samples are collected from partner sites we trust to deliver samples on time and at the highest level of quality Detailed Data: Includes donor demographics, date of diagnosis, TNM staging, treatment status and history, pathology report. Matched Sets and Controls: Matched sets and healthy controls available upon request Custom Data Sets: Available to meet specific research needs csdbio.com.ua Scientist: https://lnkd.in/eRvfbuBK [email protected] #Research #Biobank #MolecularMarkers #Oncology #Immunology #BiomedicalResearch #CSDbio

11

Prof Zarnie Lwin - updates in the treatment of gliomas - Omali Pitiyarachchi https://lnkd.in/d98uAt9X ESMO - European Society for Medical Oncology #Cancer #Glioma #CancerTreatment #ESMOAsia24 #ESMO #CancerDrug #Medicine #Health #Oncology #OncoDaily

45

#GraphicalAbstractsCollection "Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines" by Brankica Filipic, Ivana Pantelić, Ines Nikolić, Dragomira Majhen, Zorica Stojić-Vukanić , Snežana Savić, and Danina Krajišnik (University of Belgrade - Faculty of Pharmacy). This review present an overview of the most promising nanoadjuvants and nanoparticulate delivery systems and discuss their benefits from tehchnological and immunological standpoints as well as their objective drawbacks and possible side effects. The presented nano alums, silica and clay nanoparticles, nanoemulsions, adenoviral-vectored systems, adeno-associated viral vectors, vesicular stomatitis viral vectors, lentiviral vectors, virus-like particles (including bacteriophage-based ones) and virosomes indicate that vaccine developers can now choose different adjuvants and/or delivery systems as per the requirement, specific to combatting different infectious diseases. Read the full text https://lnkd.in/gPyiJpYZ #nanoadjuvants #nanoemulsions #ViralVectoredSystem #VirusLikeParticles #VLP

14

Changing environment might be a challenge for foreigner companies trying to operate in Albania with or without local representation. Here at Onyx Pharma we try to be supportive with information sharing proactively and reactively as needed. Follow our page for continues information on events and important market dynamics. #healthcareenvironment

2

🙋 Public consultation! The European #Pharmacopoeia Commission is proposing a new general chapter: Cell-based preparations for human use. This chapter aims to establish comprehensive quality requirements for the production and control of #CellBased preparations, crucial in the dynamic field of advanced therapy medicinal products. The chapter includes: 🔹 A clear definition of cell-based preparations. 🔹 General requirements applicable to all cell-based preparations. 🔹 Specific requirements for human haematopoietic stem/progenitor cells, human chondrocytes, human limbal stem cells, and human mesenchymal stromal cells. We invite all stakeholders to review the draft chapter and submit their comments! For more information: 🔗 https://lnkd.in/egC-vjvf

57

1 Comment

Meaningful discussions on lung cancer with some of the foremost researchers in the field - Elvina Almuradova https://lnkd.in/dZa5bnkS European School of Oncology #Cancer #CancerResearch #LungCancer #LungCancerAwareness #Researcher #ESOMeeting #Medicine #Health #Oncology #OncoDaily

40

Our “What is Congenital Hyperinsulinism” posters are now available in Romanian! 📣🌍️ These posters can be used to raise awareness of congenital hyperinsulinism and the signs and symptoms of hypoglycemia. We encourage you to print and share these with hospitals, physicians, friends, family, schools, or daycare. They are available for download as a two-page option, now in 25 languages! Visit https://lnkd.in/dUEVzbh to download. 🔗 #hyperinsulinism #raredisease #congenitalhyperinsulinism #hypoglycemia | Hyperinsulinism | Congenital | HI | Hypoglycemia | Rare Disease

5

Two additional studies from EHA2024 confirm validity of IWG2023 - Amer Zeidan #Cancer #EHA2024 #MyelodysplasticSyndrome #OncoDaily #Oncology #YaleUniversity

27

European Cancer Summit 2024 – Remarkable Platform to Discuss Transformative Approaches in Cancer Care - Emanuela Dodeva https://lnkd.in/dJmX6KUa European Cancer Organisation #Cancer #CancerResearch #EuropeanCancerSummit #CancerCare #UnitedAgainstCancer #PatientAdvocacy #DigitalHealth #Medicine #Health #Oncology #OncoDaily

46

1 Comment

📣 New publication: The first on plant-derived 🌿 recombinant hemopexin! This research article, published in the American Journal of Physiology (Lung Cellular and Molecular Physiology), shows that AntoXa Corporation's plant-made hemopexin product functions in an identical manner to the human (serum-derived) protein. AntoXa is a PlantForm Corporation subsidiary focused on biodefense therapeutics. Hemopexin is used to treat conditions associated with high levels of heme in serum - such as exposure to halogenated compounds (e.g., chlorine and phosgene from an industrial  accident or bioterrorism), sickle-cell disease, or from a blood transfusion. The plant-made hemopexin product opens up the potential for bulk production of hemopexin as a human biotherapeutic. This is important because the only current source is derived from donor serum and recovery rates are very low. This publication is in collaboration with our research partners at University of Alabama at Birmingham. Authors: Sadis Matalon, Zhihong Yu, Shubham Dubey, Israr Ahmad, Emily M. Stephens, Ammar Saadoon Alishlash, Ashley Meyers, Doug Cossar, Don Stewart. See the article "Hemopexin reverses activation of lung eIF2α and decreases mitochondrial injury in chlorine-exposed mice" here: https://lnkd.in/gMyCEQvN cc American Physiological Society #biopharmaceuticals #biodefense #biotech #innovation

53

1 Comment

Challenges in the Education of Young Cancer Professionals - European Cancer Organisation #DigitalisationInCancerCare #ESP #EurOncology #Cancer #Oncology #OncoDaily #CancerPrevention https://lnkd.in/gcxTazQ6

20

Tomorrow we will see you again at the HumanTech Meetings event! 🎊 📅 When: 17.05.2024 r., 12:30-14:30 📍 Where: online and onsite - Nutropharma, Jedności 10A, Lesznowola ❗ Registration for the event: https://lnkd.in/dJHiwwFj 💻 https://lnkd.in/dgh9vzKS ➡️ During the upcoming event in the HumanTech Meetings series, which we have combined with the "AI: Game Changer 2024" initiative, we will focus on key aspects of transforming quality management through artificial intelligence. AI is becoming an invaluable tool in identifying product defects, predicting the outcomes of manufacturing processes, and optimizing supply chains, offering businesses the opportunity to significantly enhance quality while reducing costs and production time. Thanks to advanced data analysis algorithms, AI systems can detect subtle anomalies that the human eye might miss, making quality management more precise and efficient than ever before. #HumanTechMeetings #AI #Technology #HumanTechCenter #HTC

4

#ESMO24 | The EU is facing a difficult situation, is it doing better in the field of oncology? Is there a European oncology represented by ESMO? Can a European oncology policy be also a resource for hashtag #globaloncology? The opinion of Andres Cervantes, ESMO President 👉 https://lnkd.in/gbr4x-vG ESMO - European Society for Medical Oncology

4

Hi! 👋 Welcome to Journal of Endocrinology's LinkedIn page! Get to know us with these three facts: ● The flagship journal of the Society for Endocrinology. Publishing basic and translational studies on endocrine physiology and metabolism. ● Led by Co-Editors-in-Chief, Professor Martin Haluzík, Charles University, Czech Republic, and Professor Ruth Andrew, The University of Edinburgh, UK, alongside an international editorial board. ● Published by Bioscientifica, with all profits redistributed to support biomedical research and practice. Find out more ➡ https://lnkd.in/eT-UUCRa #Endocrinology #ScientificJournal #OpenAccess #ScholarlyPublishing #AcademicPublishing #PeerReview

6

🔬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐫𝐨𝐦 𝐏𝐫𝐨𝐟. 𝐀𝐧𝐝𝐫𝐚𝐬 𝐒𝐳𝐚𝐬𝐳 Through recently published research we would like to offer our readers valuable insights into the role of #Oncothermia in modern oncology, highlighting its transformative effect on current treatment approaches. Explore the latest #mEHT publications from Prof. András Szász, the founder of #Oncotherm here! #Hyperthermia #Oncotherm #Publications #HyperthermicImmunoOncology

4

🔹 The utmost importance of timely and equal patient access to innovative oncology drugs across Europe was the focus of the presentation by Teodora Kolarova, INCA Executive Director, at the The Cancer Drug Development Forum (CDDF) workshop on “Clinical Research in Central and Eastern Europe: New Approaches for the Next Level of Development”.  This multi-stakeholder workshop brought together a diverse group of stakeholders to facilitate dialogue and collaboration on improving clinical research in CEE.  👉 Teodora Kolarova voiced out the cancer patient perspective and emphasized that further efforts should be placed to explore the potential role of adaptive pathways and joint HTA-EMA procedures in assuring timely and equal access to oncology medicines in the European Union.  ☑ Read more: https://lnkd.in/dzUrAA3a #LetsTalkAboutNETs #NeuroendocrineCancer #ClinicalTrials 

12

3 Comments

ESMO - European Society for Medical Oncology - We can take steps to balance the risks and benefits of sunscreen use #ESMODailyReporter #UVExposure #Cancer #OncoDaily #Oncology #CancerPrevention

17

During this European Week Against Cancer, we are reflecting on the 2023 European Cancer Forum where Nikolaj Qvist-Pedersen, MSD Oncology Lead of the Mid-Europe Region, touched on the importance of allocating adequate resources to prevention, including immunization.     By investing in preventive measures, we can improve population health and reduce the burden of vaccine-preventable diseases, including cancers.    #EWAC2024 #EUCancerPlan #Oncology #EuropeanWeekAgainstCancer 

109